Labetuzumab govitecan (IMMU-135) is an anti- CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule) antibody-drug conjugate (ADC). Labetuzumab govitecan is composed of an anti– CEACAM5 antibody, a pH-sensitive Linker, a cytotoxic agent SN38. This product is for research use only. Labetuzumab govitecan has an approximate molecular weight of 154 kDa. This product is for research use only.
Product Details |
Species Reactivity | Human |
---|
Type | Antibody-drug conjugate |
---|
ADC antibody | Labetuzumab (anti-CEACAM5) |
---|
ADC cytotoxin (drug) | SN-38 |
---|
Immunogen | Human CEACAM5 |
---|
DAR (Drug to Antibody Ratio) | N/A |
---|
Purity | 99% |
---|
Molecular Weight | 154kDa |
---|
Storage Condition | Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
---|
Storage Buffer | 1xPBS |